Medtronic received information that approximately eight months post implant of this bioprosthetic mitral valve, an echocardiogram showed valvular stenosis and elevated gradients; the mean gradients measured were measured at 25 mmhg by echocardiogram.Subsequently, the valve was replaced.The patient spent twelve days in the intensive care unit (icu) following the replacement procedure.No other adverse patient effects were reported.
|
Product analysis: upon receipt at medtronic¿s quality laboratory, the returned product specimen was visually examined.The stent posts appeared slightly deflected.Remnants of chordae tendineae were observed along the sewing ring on the outflow.A pledget remained attached to the sewing ring on the outflow adjacent to the left right stent post.The non-coronary and left cusps were stiff due to host tissue that filled and stiffened the leaflets on the inflow and outflow.The right cusp appeared partially flexible except where host tissue extends on the outflow, and the right non-coronary commissure appeared intact.Host tissue covered both the non-coronary left and left right commissures making it slightly difficult to determine the condition.Pannus remained attached to the sewing ring on the inflow extending slightly onto the tissue and base stitching, into all inferior coaptive areas and 1 to 1.5 mm onto all cusps.Pannus lined the sewing ring and outflow rails adjacent to all cusps, to the back of right non-coronary stent post and tops of the two, extending over to the tops of all commissures, encapsulating the non-coronary commissure resulting with restricted leaf let motion.Pannus on the outflow rail extended over to the inner outflow rail to the outflow margin of attachment adjacent to all cusps.Brown thrombotic appearing host tissue filled and stiffened the non-coronary and left cusps on the outflow.Remnants of brown thrombotic appearing host tissue partially filled and stiffened the right cusp on the outflow.Radiography showed no evidence of mineralization in the valve and/or host tissue.Conclusion: a review of the device history record (dhr) was performed for this valve.There were no correlations / issues identified in regard to manufacturing that could be related to this event.The device was manufactured per approved and released manufacturing processes and the device met all applicable manufacturing specifications prior to release for distribution.The impairment of leaflet mobility may have led to the thrombus formation on the outflow of the valve causing the stenosis / high gradient.
|